Catalyst Event
Innovent Biologics Inc (1801) · Other
From Akros SCHK HK-US Tech 100 Index (ASHUSTC)
3/24/2026, 12:00:00 AM
Announced that the Phase 3 STAR study of its eye disease drug Efdamrofusp Alfa (IBI302) met its primary endpoint, demonstrating non-inferiority to Eylea for treating neovascular age-related macular degeneration (nAMD). The drug also showed potential for less frequent dosing. [Estimate: Medium importance due to significant Phase 3 clinical milestone].
Korean Translation
안과 질환 치료제 이다무로푸스프 알파(IBI302)의 3상 임상(STAR 연구)이 주요 평가지표를 충족했다고 발표함. 신생혈관성 연령 관련 황반변성(nAMD) 치료에서 아일리아 대비 비열등성을 입증했으며, 투여 간격 연장 가능성을 보임. [예상: 주요 3상 임상 성공이라는 중대한 지표를 달성했으므로 'Medium'으로 분류함].
Related Recent Events
SALESFORCE INC (CRM) · Earnings Release
Salesforce's Q1 FY2027 earnings release is scheduled.
5/27/2026, 12:00:00 AM
Lenovo Group Ltd (992) · Earnings Release
Lenovo Group is scheduled to release its fourth-quarter and full-year financial results for the fiscal year 2025/2026. Price impact is estimated at ≥10% due to the significance of annual results and guidance, scheduled.
5/21/2026, 12:00:00 AM
NVIDIA Corporation (NVDA) · Earnings Release
NVIDIA's Q1 Fiscal Year 2027 earnings report is scheduled for May 20, 2026; earnings releases for major tech companies are expected to result in price movements exceeding 10% and are scheduled.
5/20/2026, 12:00:00 AM
AppLovin Corporation (APP) · Earnings Release
AppLovin's Q1 2026 earnings release is scheduled for May 13, 2026. Based on historical data where earnings results often lead to price swings over 5%, a significant market reaction is expected.
5/13/2026, 12:00:00 AM
Arista Networks Inc (ANET) · Earnings Release
Arista Networks is scheduled to release its Q1 2026 financial results with company revenue of $2.6 billion forecasted; a medium impact is estimated due to typical earnings volatility, scheduled.
5/4/2026, 12:00:00 AM
Shopify Inc (SHOP) · Earnings Release
Q1 2026 earnings release is scheduled for April 30, 2026, with revenue guidance of approximately $3.1 billion; low impact estimated as it is a routine scheduling announcement scheduled.
4/30/2026, 12:00:00 AM